The team led by Dr. Pilar Navarro has received the Carmen Delgado/Miguel Pérez-Mateo Project for pancreatic cancer research, awarded by the Pancreatic Cancer Association, the Spanish Association of Pancreatology and the Spanish Association of Gastroenterology.
The research performed by the Cancer Molecular Targets Research Group at the Barcelona Biomedical Research Institute (IIBB)-CSIC and at the IMIM-Hospital del Mar Associated Unit, led by Dr. Pilar Navarro, has obtained the eighth edition of the Carmen Delgado/Miguel Pérez-Mateo Grant in the clinical research category, awarded by the Asociación Cáncer de Páncreas, Asociación Española de Pancreatología and Asociación Española de Gastroenterología.
This project has an endowment of 50,000 euros, raised thanks to the funds obtained in the Carrera de las Ciudades contra el Cáncer de Páncreas initiative.
The winning project is called 'Validation of the detection of sAXL in plasma for early diagnosis of pancreatic cancer', and proposes to continue the work carried out by this group, which has already identified the protein tyrosine-kinase AXL as an early marker for the diagnosis of pancreatic cancer. It is the second time that this research group has obtained this recognition. In 2016, the group got the first call for this projects, but in the basic research category.
The project award ceremony took place on June 14 at the Vall d'Hebron Hospital.